定义美学的未来：市场走向成熟

Defining the Futureof Aesthetics: A MarketComing of Age An in-depth look at how evolving patient preferences,consolidation, and innovation are shaping the long-termtrajectory of the U.S. medical aesthetics market. 232626282930313334363636373839Characteristics of an Attractive Medical Spafrom an Investor’s LensPractice-Level Performance IndicatorsSame-store Practice Growth AnalysisRegional Practice Growth AnalysisPatient Spending TrendMedical Aesthetics Patient Age GenerationCompositionSpending Behaviors by Age GroupSpending Behaviors by GenderM&A Activity and SummarySWOT AnalysisThe State of Medical AestheticsStrengthsWeaknessesOpportunitiesThreats 020203040507IntroductionGuiding the Next Phase of Aesthetics Industry GrowthAbout SkytaleAbout QsightData Sources/SolutionsExecutive Summary 08State of the Overall Aesthetics Industry 1111131516Key Aesthetics HighlightsSkilled WorkersValuationsActive ConsolidationCompetition 17State of the Aesthetics Industry by Segment 1718192021NeurotoxinsDermal FillersEnergy-Based DevicesProfessional Grade SkincareWeight Loss 4040Final WordsConclusion 2222Medical Aesthetics Practice InsightsKey TakeawaysTable of Contents The medical aesthetics industry continues to developin its maturity and adoption of data-driven analysisand market-aware decision-making. Qsight and Skytalehave partnered to share their research, analysis, andexperience in medical aesthetics, offering our combinedexpertise and insights to help guide the industry throughits next phase of growth. INTRODUCTION Guiding theNext Phaseof AestheticsIndustry Growth Skytale brings years of expertise and relationships inoffering investment banking, management consulting,and private capital solutions. Qsight specializes inproviding comprehensive data solutions for the medicalaesthetics, MedTech, and financial services industries.Together, we are proud to present this whitepapercontaining our exclusive and original perspectiveson the state of the medical aesthetics industry. in 4 medical aesthetic organizations since 2024. INTRODUCTION Founded in 2018 and headquartered in Dallas, Texas,Skytale has a national presence providing guidance andperspective to clients across multiple healthcare specialties.Skytale appreciates what their clients are building and is dedi-cated to becoming a trusted partner by delivering tailored solu-tions designed to bring value to each organization’s vision. About Skytale Skytale is a leading investment banking, managementconsulting, and private capital solutions firm offeringstrategic and advisory services to healthcare and consumerbusinesses nationwide. Skytale Investment Banking consists oflicensed investment bankers who have extensive experience inmergers and acquisitions, while Skytale ManagementConsulting provides services centered on evidence-basedstrategy to grow healthcare organizations, and privatecapital advisory capabilities within healthcare. In theaesthetics space alone, Skytale has completed over 20transactions since 2022, and Skytale Capital has invested Skytale’s team of investment and financial advisors and C-lev-el executives have decades of hands-on experience and areequipped to guide businesses to the next level. Using the inter-section of business intelligence and client personal goals, theirteam can help guide business owners to meet their ambitionsand goals. INTRODUCTION and financial services. For the medical aesthetics industry,our proprietary data assets enable unparalleled insightsinto a range of topics including transaction-level patientpurchasing behaviors, expert aesthetics opinions collectedfrom hundreds of practitioners across the world, and fullmarket sizing of the entire U.S. aesthetics industry. About Qsight Guidepoint Qsight is the premier provider of data, insights,and analytics for stakeholders in the medical aestheticsand MedTech industries, including leading institutionalinvestors, manufacturers, and service providers. Foundedas Quanton Data and acquired by Guidepoint in 2016,Qsight’s offerings provide insights into usage, purchasingpatterns, and consumer behavior in some of the mostdynamic marketsin these industries. Qsight is a division of Guidepoint, a global expertnetwork that connects clients with industry professionals,subject matter experts, and thought leaders across varioussectors and disciplines. Guidepoint’s expansive network,consisting of over one million experts worldwide, providesstrategic guidance and decision-making support to clientsin order to drive business success. Backed by Qsight’s team of data scientists, data engineers,and industry experts, our solutions are trusted by some ofthe largest corporations in medical aesthetics, MedTech, Data Sources/Solutions This whitepaper is supported by the following Skytale + Qsight resources: Pitchbook:Pitchbook provides capital market data and intelligence solutions that help understandcurrent market conditions and transaction details. Skytale Internal Practice Data:Sk